U.S. to partner with Big Pharma for drug discovery

<p>CHICAGO/WASHINGTON (Reuters) – The U.S. supervision will assistance <span>drug companies</span> find treatments for a horde of diseases by a new <span>collaboration</span> in that researchers will exam initial drugs supposing by manufacturers.</p>
<p> The <span>National Institutes of Health</span> pronounced on Thursday that <span>Pfizer Inc</span>, <span>AstraZeneca</span> Plc and Eli Lilly and Co have concluded to make 24 <span>compounds</span> accessible for a commander proviso of a project, a biggest of a kind ever launched in a United States.</p>
<p> All of a compounds have been attempted in people and found to be safe, yet a drugmakers have deserted them since they did not work for a illness they were dictated to treat. The <span>NIH</span> will yield $20 million in grants any year to researchers perplexing to find new uses for a compounds...